126 related articles for article (PubMed ID: 23926960)
1. Long-term visual outcomes in patients with orbitotemporal neurofibromatosis.
Greenwell TH; Anderson PJ; Madge SK; Selva D; David DJ
Clin Exp Ophthalmol; 2014 Apr; 42(3):266-70. PubMed ID: 23926960
[TBL] [Abstract][Full Text] [Related]
2. Visual loss in orbitofacial neurofibromatosis type 1.
Oystreck DT; Morales J; Chaudhry I; Alorainy IA; Elkhamary SM; Pasha TM; Bosley TM
Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
[TBL] [Abstract][Full Text] [Related]
3. Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.
Chaudhry IA; Morales J; Shamsi FA; Al-Rashed W; Elzaridi E; Arat YO; Jacquemin C; Oystreck DT; Bosley TM
Eye (Lond); 2012 Apr; 26(4):583-92. PubMed ID: 22193879
[TBL] [Abstract][Full Text] [Related]
4. Orbitotemporal neurofibromatosis. Clinical features and surgical management.
Lee V; Ragge NK; Collin JR
Ophthalmology; 2004 Feb; 111(2):382-8. PubMed ID: 15019395
[TBL] [Abstract][Full Text] [Related]
5. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.
Avery RA; Dombi E; Hutcheson KA; Acosta MT; Baldwin AM; Madigan WP; Gillespie A; Fitzgibbon EJ; Packer RJ; Widemann BC
Am J Ophthalmol; 2013 Jun; 155(6):1089-1094.e1. PubMed ID: 23453281
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and surgical management of orbitotemporal neurofibromatosis: a retrospective interventional case series.
Altan-Yaycioglu R; Hintschich C
Orbit; 2010 Oct; 29(5):232-8. PubMed ID: 20812827
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
Thiagalingam S; Flaherty M; Billson F; North K
Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and causes of visual impairment in craniosynostotic syndromes.
Tay T; Martin F; Rowe N; Johnson K; Poole M; Tan K; Kennedy I; Gianoutsos M
Clin Exp Ophthalmol; 2006 Jul; 34(5):434-40. PubMed ID: 16872339
[TBL] [Abstract][Full Text] [Related]
10. Ocular motility abnormalities in orbitofacial neurofibromatosis type 1.
Oystreck DT; Alorainy IA; Morales J; Chaudhry IA; Elkhamary SM; Bosley TM
J AAPOS; 2014 Aug; 18(4):338-43. PubMed ID: 25173895
[TBL] [Abstract][Full Text] [Related]
11. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic findings in Apert's syndrome after craniofacial surgery: twenty-nine years' experience.
Khong JJ; Anderson P; Gray TL; Hammerton M; Selva D; David D
Ophthalmology; 2006 Feb; 113(2):347-52. PubMed ID: 16458095
[TBL] [Abstract][Full Text] [Related]
13. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type.
Gizicki R; Robert MC; Gómez-López L; Orquin J; Decarie JC; Mitchell GA; Roy MS; Ospina LH
Ophthalmology; 2014 Jan; 121(1):381-386. PubMed ID: 24126030
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Analysis of Vision-Impairing Tumors Among 467 Patients with Neurofibromatosis Type 2.
Li P; Wang Z; Zhou Q; Li S; Zhang J; Wang Y; Wang X; Wang B; Zhao F; Liu P; Yang Z
World Neurosurg; 2017 Jan; 97():557-564. PubMed ID: 27777154
[TBL] [Abstract][Full Text] [Related]
15. Labial neurofibroma as the presenting feature of genital and orbitotemporal neurofibromatosis.
Dutta D; Roy A; Mukhopadhyay S; Chowdhury S
Indian J Pediatr; 2014 Aug; 81(8):829-30. PubMed ID: 24374492
[No Abstract] [Full Text] [Related]
16. Orbitotemporal neurofibromatosis: classification and treatment.
Erb MH; Uzcategui N; See RF; Burnstine MA
Orbit; 2007 Dec; 26(4):223-8. PubMed ID: 18097958
[TBL] [Abstract][Full Text] [Related]
17. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
18. [Difficult surgical management of facial neurofibromatosis type I or von Recklinghausen disease in children].
Heuze Y; Piot B; Mercier J
Rev Stomatol Chir Maxillofac; 2002 Apr; 103(2):105-13. PubMed ID: 11997738
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
Kelly JP; Leary S; Khanna P; Weiss AH
Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of cervical spine manifestations of neurofibromatosis Type 1: long-term clinical and radiological follow-up in 22 cases.
Taleb FS; Guha A; Arnold PM; Fehlings MG; Massicotte EM
J Neurosurg Spine; 2011 Mar; 14(3):356-66. PubMed ID: 21235302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
